Literature DB >> 22360509

Phyllodes tumor of the prostate.

Tomomi Fujii1, Keiji Shimada, Nobumichi Tanaka, Kiyohide Fujimoto, Noboru Konishi.   

Abstract

In this report, we describe a case of phyllodes tumor of the prostate with a high value of prostate-specific antigen (PSA). A 47-year-old man with symptoms of hematospermia presented with a steadily elevated serum PSA value of 60.76 ng/mL (normal range, < 4 ng/mL). A needle biopsy revealed atypical stromal cells without any evidence of malignancy. After radical prostatectomy, the tumor measured 2.9 cm in diameter and consisted of a single nodule composed of irregular, elongated epithelial ducts and atypical stromal cells with enlarged, occasionally multinucleated, pleomorphic, or hyperchromatic nuclei. Immunohistochemistry showed that the atypical stromal cells were positive for vimentin, androgen receptor, estrogen receptor, progesterone, and 5α-reductase, but negative for MIB-1, PSA, SMA, p53, desmin, CD34, c-kit, CD10, S-100, and EGFR. Excess PSA might be secreted by hyperplastic luminal cells driven by 5α-reductase-positive stromal and epithelial cells. Array-comparative genomic hybridization (array CGH) for genomic alterations revealed a gain of 11p13, which includes the WT1 gene, and a loss of 1p36.23 and 12p12.1. After surgery, the serum PSA value rapidly decreased to within the normal range; no recurrence or distant metastasis was noted after 2 years of follow up.
© 2012 The Authors. Pathology International © 2012 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22360509     DOI: 10.1111/j.1440-1827.2012.02796.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Benign phyllodes tumour of the prostate: An extremely rare entity.

Authors:  Ozgu Aydogdu; Yusuf Ziya Atesci; Ayhan Karakose; Eren Demirtas
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

2.  Multidisciplinary treatment including systemic chemotherapy for a malignant phyllodes tumour of the prostate.

Authors:  Yasukiyo Murakami; Ken-Ichi Tabata; Atsushi Sugita; Kohei Mochizuki; Ryota Maeyama; Miyoko Okazaki; Morihiro Nishi; Kazumasa Matsumoto; Tetsuo Fujita; Takefumi Satoh; Shi-Xu Jiang; Makoto Saegusa; Masatsugu Iwamura
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

3.  Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.

Authors:  Jin-Jin Lin; Chiun-Sheng Huang; John Yu; Guo-Shiou Liao; Huang-Chun Lien; Jung-Tung Hung; Ruey-Jen Lin; Fen-Pi Chou; Kun-Tu Yeh; Alice L Yu
Journal:  Breast Cancer Res       Date:  2014-03-26       Impact factor: 6.466

4.  Phyllodes tumor of the prostate: Long-term follow up of a rare condition.

Authors:  Ali Razi; Seyed Reza Yahyazadeh; Hiva Saffar
Journal:  Urol Case Rep       Date:  2019-09-17

5.  A rare rectal gastrointestinal stromal tumor with indolent biological behavior: A case study.

Authors:  Jian Yang; Ying Liu; Xue-Jia Sun; Zhong-Wei Ai; Shi Liu
Journal:  Exp Ther Med       Date:  2022-08-30       Impact factor: 2.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.